BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 23629863)

  • 21. DC-STAMP Is an Osteoclast Fusogen Engaged in Periodontal Bone Resorption.
    Wisitrasameewong W; Kajiya M; Movila A; Rittling S; Ishii T; Suzuki M; Matsuda S; Mazda Y; Torruella MR; Azuma MM; Egashira K; Freire MO; Sasaki H; Wang CY; Han X; Taubman MA; Kawai T
    J Dent Res; 2017 Jun; 96(6):685-693. PubMed ID: 28199142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo.
    Kim JY; Min JY; Baek JM; Ahn SJ; Jun HY; Yoon KH; Choi MK; Lee MS; Oh J
    Bone; 2015 Oct; 79():242-51. PubMed ID: 26103094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oridonin ameliorates inflammation-induced bone loss in mice via suppressing DC-STAMP expression.
    Zou BH; Tan YH; Deng WD; Zheng JH; Yang Q; Ke MH; Ding ZB; Li XJ
    Acta Pharmacol Sin; 2021 May; 42(5):744-754. PubMed ID: 32753731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The collection of NFATc1-dependent transcripts in the osteoclast includes numerous genes non-essential to physiologic bone resorption.
    Charles JF; Coury F; Sulyanto R; Sitara D; Wu J; Brady N; Tsang K; Sigrist K; Tollefsen DM; He L; Storm D; Aliprantis AO
    Bone; 2012 Nov; 51(5):902-12. PubMed ID: 22985540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin-27 inhibits human osteoclastogenesis by abrogating RANKL-mediated induction of nuclear factor of activated T cells c1 and suppressing proximal RANK signaling.
    Kalliolias GD; Zhao B; Triantafyllopoulou A; Park-Min KH; Ivashkiv LB
    Arthritis Rheum; 2010 Feb; 62(2):402-13. PubMed ID: 20112358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resolvin E1 Inhibits Osteoclastogenesis and Bone Resorption by Suppressing IL-17-induced RANKL Expression in Osteoblasts and RANKL-induced Osteoclast Differentiation.
    Funaki Y; Hasegawa Y; Okazaki R; Yamasaki A; Sueda Y; Yamamoto A; Yanai M; Fukushima T; Harada T; Makino H; Shimizu E
    Yonago Acta Med; 2018 Mar; 61(1):8-18. PubMed ID: 29599617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Osteon Myospalacem Baileyi attenuates osteoclast differentiation through RANKL induced NFAT pathways.
    Cui Y; Zhao X; Mei L; Pei J; Wang S; Shao Y; Tao Y; Zhang X; Jiang L
    J Ethnopharmacol; 2018 Mar; 213():65-71. PubMed ID: 29107144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Receptor activator of nuclear factor-kappaB ligand-induced nuclear factor of activated T cells (C1) autoregulates its own expression in osteoclasts and mediates the up-regulation of tartrate-resistant acid phosphatase.
    Fretz JA; Shevde NK; Singh S; Darnay BG; Pike JW
    Mol Endocrinol; 2008 Mar; 22(3):737-50. PubMed ID: 18063694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RNA-binding protein Musashi2 induced by RANKL is critical for osteoclast survival.
    Fujiwara T; Zhou J; Ye S; Zhao H
    Cell Death Dis; 2016 Jul; 7(7):e2300. PubMed ID: 27441652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The fungal metabolite (+)-terrein abrogates osteoclast differentiation via suppression of the RANKL signaling pathway through NFATc1.
    Nakagawa S; Omori K; Nakayama M; Mandai H; Yamamoto S; Kobayashi H; Sako H; Sakaida K; Yoshimura H; Ishii S; Ibaragi S; Hirai K; Yamashiro K; Yamamoto T; Suga S; Takashiba S
    Int Immunopharmacol; 2020 Jun; 83():106429. PubMed ID: 32222639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Water extract of Spatholobus suberectus inhibits osteoclast differentiation and bone resorption.
    Ha H; Shim KS; An H; Kim T; Ma JY
    BMC Complement Altern Med; 2013 May; 13():112. PubMed ID: 23692684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular basis of requirement of receptor activator of nuclear factor κB signaling for interleukin 1-mediated osteoclastogenesis.
    Jules J; Zhang P; Ashley JW; Wei S; Shi Z; Liu J; Michalek SM; Feng X
    J Biol Chem; 2012 May; 287(19):15728-38. PubMed ID: 22416138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aspirin inhibits RANKL-induced osteoclast differentiation in dendritic cells by suppressing NF-κB and NFATc1 activation.
    Wu L; Luo Z; Liu Y; Jia L; Jiang Y; Du J; Guo L; Bai Y; Liu Y
    Stem Cell Res Ther; 2019 Dec; 10(1):375. PubMed ID: 31805984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accelerated Lactate Dehydrogenase Activity Potentiates Osteoclastogenesis via NFATc1 Signaling.
    Ahn H; Lee K; Kim JM; Kwon SH; Lee SH; Lee SY; Jeong D
    PLoS One; 2016; 11(4):e0153886. PubMed ID: 27077737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influence of interleukin-32γ on osteoclastogenesis with a focus on fusion-related genes.
    Kim YG; So MW; Koo BS; Chang EJ; Song SJ; Lee CK; Yoo B
    J Clin Immunol; 2012 Feb; 32(1):201-6. PubMed ID: 22068911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulators of osteoclast differentiation and cell-cell fusion.
    Miyamoto T
    Keio J Med; 2011; 60(4):101-5. PubMed ID: 22200633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Esculetin attenuates receptor activator of nuclear factor kappa-B ligand-mediated osteoclast differentiation through c-Fos/nuclear factor of activated T-cells c1 signaling pathway.
    Baek JM; Park SH; Cheon YH; Ahn SJ; Lee MS; Oh J; Kim JY
    Biochem Biophys Res Commun; 2015 May; 461(2):334-41. PubMed ID: 25887803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chlorogenic acid inhibits osteoclast differentiation and bone resorption by down-regulation of receptor activator of nuclear factor kappa-B ligand-induced nuclear factor of activated T cells c1 expression.
    Kwak SC; Lee C; Kim JY; Oh HM; So HS; Lee MS; Rho MC; Oh J
    Biol Pharm Bull; 2013; 36(11):1779-86. PubMed ID: 23985829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of a rare genetic variant of TM7SF4 gene on osteoclasts of patients with Paget's disease of bone.
    Laurier E; Amiable N; Gagnon E; Brown JP; Michou L
    BMC Med Genet; 2017 Nov; 18(1):133. PubMed ID: 29145829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcriptional Modulator Ifrd1 Regulates Osteoclast Differentiation through Enhancing the NF-κB/NFATc1 Pathway.
    Iezaki T; Fukasawa K; Park G; Horie T; Kanayama T; Ozaki K; Onishi Y; Takahata Y; Nakamura Y; Takarada T; Yoneda Y; Nakamura T; Vacher J; Hinoi E
    Mol Cell Biol; 2016 Oct; 36(19):2451-63. PubMed ID: 27381458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.